Redirect

segunda-feira, 13 de janeiro de 2014

India Ink: Ranbaxy Says F.D.A. Lists Possible Violations at Punjab Drug Plant


NYT > World

India Ink: Ranbaxy Says F.D.A. Lists Possible Violations at Punjab Drug Plant

The latest warning from the American regulator comes four months after it announced a ban on any imports made by another Ranbaxy factory.
    









Nenhum comentário:

Postar um comentário